Cargando…

Modelling the consequences of a reduction in alcohol consumption among patients with alcohol dependence based on real-life observational data

BACKGROUND: Most available pharmacotherapies for alcohol-dependent patients target abstinence; however, reduced alcohol consumption may be a more realistic goal. Using randomized clinical trial (RCT) data, a previous microsimulation model evaluated the clinical relevance of reduced consumption in te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahhali, Nora, Millier, Aurélie, Briquet, Benjamin, Laramée, Philippe, Aballéa, Samuel, Toumi, Mondher, François, Clément, Rehm, Jürgen, Daeppen, Jean-Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687312/ https://www.ncbi.nlm.nih.gov/pubmed/26690081 http://dx.doi.org/10.1186/s12889-015-2606-4

Ejemplares similares

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model
por: Laramée, Philippe, et al.
Publicado: (2014)

Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
por: Roerecke, Michael, et al.
Publicado: (2015)

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
por: Zhou, Junwen, et al.
Publicado: (2019)

The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients
por: François, Clément, et al.
Publicado: (2015)

Alcohol Dependence and Mortality: Implications for Treatment — Authors' Reply
por: Laramée, Philippe, et al.
Publicado: (2015)

Quality of life is predictive of relapse in schizophrenia
por: Boyer, Laurent, et al.
Publicado: (2013)

Risk of All-Cause Mortality in Alcohol-Dependent Individuals: A Systematic Literature Review and Meta-Analysis()
por: Laramée, Philippe, et al.
Publicado: (2015)

Determinants of orphan drugs prices in France: a regression analysis
por: Korchagina, Daria, et al.
Publicado: (2017)

Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population
por: Toumi, Mondher, et al.
Publicado: (2020)

Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment
por: Toumi, Mondher, et al.
Publicado: (2017)

Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
por: Millier, Aurelie, et al.
Publicado: (2011)

Current process and future path for health economic assessment of pharmaceuticals in France
por: Toumi, Mondher, et al.
Publicado: (2015)

The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Economic Impact of a triptan Rx-To-OTC Switch in Six EU Countries
por: Millier, Aurelie, et al.
Publicado: (2013)

Drug repurposing in pharmaceutical industry and its impact on market access: market access implications
por: Murteira, Susana, et al.
Publicado: (2014)

Systematic review of pharmacoeconomic models for schizophrenia
por: Zhou, Junwen, et al.
Publicado: (2018)

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
por: Bowrin, Kevin, et al.
Publicado: (2020)

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
por: Toumi, Mondher, et al.
Publicado: (2020)

Alcohol consumption, alcohol dependence, and related mortality in Italy in 2004: effects of treatment-based interventions on alcohol dependence
por: Shield, Kevin D, et al.
Publicado: (2013)

A prospective study of health care resource utilisation and selected costs of schizophrenia in France
por: Sarlon, Emmanuelle, et al.
Publicado: (2012)

Alcohol and cannabis use as risk factors for injury – a case-crossover analysis in a Swiss hospital emergency department
por: Gmel, Gerhard, et al.
Publicado: (2009)

Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives
por: Chachoua, Lylia, et al.
Publicado: (2020)

Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach
por: Han, Ru, et al.
Publicado: (2021)

Economic burden associated with alcohol dependence in a German primary care sample: a bottom-up study
por: Manthey, Jakob, et al.
Publicado: (2016)

Predictive models to estimate utility from clinical questionnaires in schizophrenia: findings from EuroSC
por: Siani, Carole, et al.
Publicado: (2015)

Attitudes and beliefs of the French public about schizophrenia and major depression: results from a vignette-based population survey
por: Angermeyer, Matthias C, et al.
Publicado: (2013)

Global burden of injuries attributable to alcohol consumption in 2004: a novel way of calculating the burden of injuries attributable to alcohol consumption
por: Shield, Kevin D, et al.
Publicado: (2012)

Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France
por: Bowrin, Kevin, et al.
Publicado: (2020)

Measuring the health-related quality of life in young children: how far have we come?
por: Germain, Nicola, et al.
Publicado: (2019)

Factors influencing the COVID-19 daily deaths' peak across European countries
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Quantifying the global contribution of alcohol consumption to cardiomyopathy
por: Manthey, Jakob, et al.
Publicado: (2017)

Alcohol taxation, alcohol consumption and cancers in Lithuania: A case study
por: Rovira, Pol, et al.
Publicado: (2021)

Time of injury in light of prior-to-injury and usual alcohol consumption: an emergency department study
por: Kuendig, Hervé, et al.
Publicado: (2010)

Externalities from Alcohol Consumption in the 2005 US National Alcohol Survey: Implications for Policy
por: Greenfield, Thomas K., et al.
Publicado: (2009)

Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations
por: Thokagevistk, Katia, et al.
Publicado: (2016)

The Risks Associated With Alcohol Use and Alcoholism
por: Rehm, Jürgen
Publicado: (2011)

The effects of capping the alcohol consumption distribution and relative risk functions on the estimated number of deaths attributable to alcohol consumption in the European Union in 2004
por: Gmel, Gerrit, et al.
Publicado: (2013)

Health economic evaluation of gene replacement therapies: methodological issues and recommendations
por: Aballéa, Samuel, et al.
Publicado: (2020)

Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms
por: Kehoe, Tara, et al.
Publicado: (2012)

Reduction of Alcoholic Strength: Does It Matter for Public Health?
por: Rehm, Jürgen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7nj0ltc0qgn07bv0pcfc7qjkqn